Articles by Disease (Hematological Malignancies)

From Bone Marrow Transplantation to Cellular Therapies: Possible Therapeutic Strategies in Managing Autoimmune Disorders

Journal: Current Pharmaceutical Design
Volume: 18
Page: 5776-5781
Author(s): Andrea Taddio, Andrea Biondi, Elisa Piscianz, Erica Valencic, Ettore Biagi and Raffaele Badolato

State of the Art of the Therapeutic Perspective of Sorafenib Against Hematological Malignancies

Journal: Current Medicinal Chemistry
Volume: 19
Page: 4875-4884
Author(s): G. Zauli, R. Voltan, V. Tisato and P. Secchiero

Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution

Journal: Current Molecular Medicine
Volume: 12
Page: 1108-1124
Author(s): L. Whitesell, S. Santagata and N.U. Lin

Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 11
Page: 351-363
Author(s): Albert J. Czaja

Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part I

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 11
Page: 337-350
Author(s): Albert J. Czaja

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib

Journal: Current Medicinal Chemistry
Volume: 19
Page: 4399-4413
Author(s): J. Mascarenhas, T. I. Mughal and S. Verstovsek

Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials

Journal: Current Medicinal Chemistry
Volume: 19
Page: 4377-4398
Author(s): I. Balderas-Renteria, P. Gonzalez-Barranco, A. Garcia, B. K. Banik and G. Rivera